TY - JOUR T1 - Canonical and cross-reactive binding of NK cell inhibitory receptors to HLA-C allotypes is dictated by peptides bound to HLA-C JF - bioRxiv DO - 10.1101/096958 SP - 096958 AU - Malcolm J. W. Sim AU - Stacy A. Malaker AU - Ayesha Khan AU - Janet M. Stowell AU - Jeffrey Shabanowitz AU - Mary E. Peterson AU - Sumati Rajagopalan AU - Donald F. Hunt AU - Daniel M. Altmann AU - Eric O. Long AU - Rosemary J. Boyton Y1 - 2016/01/01 UR - http://biorxiv.org/content/early/2016/12/27/096958.abstract N2 - Background Human natural killer (NK) cell activity is regulated by a family of killer-cell Ig-like receptors (KIR) that bind human leucocyte antigen (HLA) class I. Combinations of KIR and HLA genotypes are associated with disease, including susceptibility to viral infection and disorders of pregnancy. KIR2DL1 binds HLA-C alleles of group C2 (Lys80) and KIR2DL2 and KIR2DL3 bind HLA-C alleles of group C1 (Asn80). However, this model does not capture allelic diversity in HLA-C or the impact of HLA-bound peptides. The goal of this study was to determine the extent to which the endogenous HLA-C peptide repertoire can influence the specific binding of inhibitory KIR to HLA-C allotypes.Results The impact of HLA-C bound peptide on inhibitory KIR binding was investigated taking advantage of the fact that HLA-C*05:01 (HLA-C group 2, C2) and HLA-C*08:02 (HLA-C group 1, C1) have identical sequences apart from the key KIR specificity determining epitope at residues 77 and 80. Endogenous peptides were eluted from HLA-C*05:01 and used to test the peptide dependence of KIR2DL1 and KIR2DL2/3 binding to HLA-C*05:01 and HLA-C*08:02 and subsequent impact on NK cell function. Specific binding of KIR2DL1 to the C2 allotype occurred with the majority of peptides tested. In contrast, KIR2DL2/3 binding to the C1 allotype occurred with only a subset of peptides. Cross-reactive binding of KIR2DL2/3 with the C2 allotype was restricted to even fewer peptides. Unexpectedly, two peptides promoted binding of the C2 allotype-specific KIR2DL1 to the C1 allotype. We showed that presentation of endogenous peptides, or predicted HIV Gag peptides, by HLA-C can promote KIR cross-reactive binding.Conclusions KIR2DL2/3 binding to C1 is more peptide selective than that of KIR2DL1 binding to C2, which provides an explanation for why KIR2DL3–C1 interactions appear weaker than KIR2DL1–C2. In addition, cross-reactive binding of KIR is characterized by even higher peptide selectivity. We demonstrate a hierarchy of functional peptide selectivity of KIR–HLA-C interactions with relevance to NK cell biology and human disease associations. This selective peptide sequence-driven binding of KIR provides a potential mechanism for pathogen as well as self-peptide to modulate NK cell activation through altering levels of inhibition.CD3cluster of differentiation 3CHAPS3-[(3-Cholamidopropyl) dimethyl ammonio]-1-propanesulfonateCMVCytomegalovirusEBVEpstein–Barr virusEDTAEthylenediaminetetraacetic acidFACSFluorescence activated cell sortingGFPGreen fluorescent proteinHCVHerpes simplex virusHIVHuman immunodeficiency virusHLAHuman leukocyte antigenKIRKiller-cell immunoglobulin-like receptorMFIMedian fluorescence intensityNKcell Natural killer cellPBMCPeripheral blood mononuclear cellPBSPhosphate-buffered salineSEMStandard error of the meanSPsingle positiveTAPTransporter associated with antigen processingVSVVesicular stomatitis virus ER -